Holen Sie sich die Stockscreener-App
2.06
7.21%
-0.16
Handel nachbörslich:
2.06
Schlusskurs vom Vortag:
$2.22
Offen:
$2.23
24-Stunden-Volumen:
345.43K
Relative Volume:
0.77
Marktkapitalisierung:
$260.19M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-70.78M
KGV:
-3.6786
EPS:
-0.56
Netto-Cashflow:
$-61.27M
1W Leistung:
+7.85%
1M Leistung:
+0.98%
6M Leistung:
+153.41%
1J Leistung:
+13.19%
1-Tages-Spanne:
$2.02
$2.24
1-Wochen-Bereich:
$1.855
$2.2901
52-Wochen-Spanne:
$0.62
$2.54
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Firmenname
Nautilus Biotechnology Inc
Sektor
Branche
Telefon
206-333-2001
Adresse
2701 EASTLAKE AVE EAST, SEATTLE
Vergleichen Sie NAUT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
2.06 | 280.40M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
| 2024-06-27 | Eingeleitet | Guggenheim | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2022-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-11-02 | Eingeleitet | Cowen | Outperform |
| 2021-08-04 | Eingeleitet | Goldman | Neutral |
| 2021-07-13 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Nautilus Biotechnology Inc Aktie (NAUT) Neueste Nachrichten
Why Nautilus Biotechnology Inc. stock could rally in 2025GDP Growth & Free Safe Capital Growth Stock Tips - ulpravda.ru
Will Nautilus Biotechnology Inc. stock deliver consistent dividendsWeekly Profit Report & Risk Controlled Swing Alerts - ulpravda.ru
Why analysts upgrade Nautilus Biotechnology Inc. stock2025 Earnings Surprises & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay - MarketScreener
Nautilus Biotechnology Insiders May Regret Not Buying More, Market Cap Hits US$236m - simplywall.st
3 Penny Stocks With Market Caps Under $700M - simplywall.st
Will Nautilus Biotechnology Inc. stock outperform tech sector in 20252026 world cup usa national team qualification defensive leaders set piece tactics group prediction preview - ulpravda.ru
Corient Private Wealth LLC Acquires 390,000 Shares of Nautilus Biotechnology, Inc. $NAUT - Defense World
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) boasts of bullish insider sentiment with 33% ownership and they have been buying lately - Yahoo Finance
Nautilus Biotechnology Faces Nasdaq Delisting Risk Amid Compliance Challenges - MSN
Aug Fed Impact: Is Nautilus Biotechnology Inc stock attractive for income investorsJuly 2025 PostEarnings & Fast Gain Swing Trade Alerts - moha.gov.vn
How buybacks impact Nautilus Biotechnology Inc. stock valueJuly 2025 Trends & Verified Swing Trading Watchlists - Улправда
Will Nautilus Biotechnology Inc. stock attract more institutional investors - Улправда
Published on: 2025-12-20 14:57:12 - moha.gov.vn
Nautilus Biotechnology Earnings Notes - Trefis
Why Nautilus Biotechnology Inc. stock remains on buy lists2025 Market WrapUp & Community Consensus Picks - bolumsonucanavari.com
Is Nautilus Biotechnology Inc. stock a safe buy before earnings2025 Analyst Calls & Long-Term Growth Stock Strategies - DonanımHaber
ETF Watch: Is Nautilus Biotechnology Inc. stock a safe buy before earningsJuly 2025 Retail & Step-by-Step Trade Execution Guides - DonanımHaber
Is Nautilus Biotechnology Inc. stock supported by strong fundamentalsJuly 2025 Highlights & Verified Swing Trading Watchlist - Улправда
Is Nautilus Biotechnology Inc. stock a buy before product launches2025 Volatility Report & Capital Efficiency Focused Ideas - Улправда
Nautilus Biotechnology drives innovation in proteomics space - Traders Union
Nautilus Biotechnology (NAUT) Stock Analysis Report | Financials & Insights - Benzinga
Nautilus Biotechnology: Divergent Signals from Investors and Analysts - AD HOC NEWS
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 0.5%Here's What Happened - MarketBeat
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 0.5% – Here’s What Happened - Defense World
Is Nautilus Biotechnology Inc a good long term investmentEconomic Indicators Overview & Small Budget Portfolio Growth - earlytimes.in
Penny Stocks To Consider In December 2025 - simplywall.st
Investment Report: Will Nautilus Biotechnology Inc. stock attract more institutional investorsEarnings Growth Report & Technical Buy Zone Confirmations - moha.gov.vn
Adversity is less terrifying than hope: Nautilus Biotechnology Inc (NAUT) - setenews.com
Advancing next-generation proteomics with single-molecule Iterative Mapping - Select Science
There is no way Nautilus Biotechnology Inc (NAUT) can keep these numbers up - Setenews
Advanced analytics toolkit walkthrough for Nautilus Biotechnology Inc.2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
What dividend safety score for Nautilus Biotechnology Inc. stockMarket Growth Report & Low Volatility Stock Recommendations - newser.com
Long term hold vs stop loss in Nautilus Biotechnology Inc.Market Risk Summary & Daily Profit Focused Stock Screening - newser.com
Will Nautilus Biotechnology Inc. stock maintain momentum in 2025Recession Risk & Low Drawdown Investment Ideas - newser.com
Has Nautilus Biotechnology Inc. found a price floorMarket Growth Summary & Free High Accuracy Swing Entry Alerts - newser.com
What candlestick patterns are forming on Nautilus Biotechnology Inc.Weekly Trend Recap & Reliable Price Breakout Signals - newser.com
Will Nautilus Biotechnology Inc. stock outperform value stocksMarket Trend Summary & Reliable Volume Spike Trade Alerts - newser.com
Why Nautilus Biotechnology Inc. stock is recommended by analystsMarket Activity Summary & Risk Controlled Swing Trade Alerts - newser.com
Wall Street Zen Upgrades Nautilus Biotechnology (NASDAQ:NAUT) to Hold - MarketBeat
How to recover losses in Nautilus Biotechnology Inc. stockBull Run & Technical Entry and Exit Alerts - newser.com
Why Nautilus Biotechnology Inc. stock is considered a top pickMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Nautilus Biotechnology Inc. stock oversold or undervaluedEarnings Overview Summary & Free High Return Stock Watch Alerts - newser.com
How Nautilus Biotechnology Inc. stock performs in rate cut cyclesPortfolio Update Report & Community Trade Idea Sharing Platform - newser.com
Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):